Japan Ends Full Coverage For COVID Therapeutics, Pharma Braces For Price Cuts

 
• By Lisa Takagi
  
Copayment for COVID therapeutics will be gradually higher for patients to reach the standard of Japan’s NHI scheme by April.
Co-payments for COVID therapeutics in Japan set to rise • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia